Testing effectiveness (Phase 2)Study completedNCT03109158
What this trial is testing
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
NanoCarrier Co., Ltd. 1